Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Advances in the management of multiple sclerosis spasticity: recent clinical trials.
The conundrum of interferon-β non-responsiveness in relapsing-remitting multiple sclerosis.
Beyond Depression: Predictors of Self-Reported Cognitive Function in Adults Living With MS.
Synthesis and characterization of a novel Gd-based contrast agent for magnetic resonance imaging of myelination.
The astrocyte in multiple sclerosis revisited.
Mechanistic Perspectives of Maslinic Acid in Targeting Inflammation.
Visual field characteristics in neuromyelitis optica in absence of and after one episode of optic neuritis.
Access to Multiple Sclerosis Specialty Care.
Acute disseminated encephalomyelitis: the importance of early magnetic resonance imaging.
Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases.
Decreased Myelinated Fibers in the Hippocampal Dentate Gyrus of the Tg2576 Mouse Model of Alzheimer's Disease.
Multiple sclerosis - New treatment modalities.
Neuregulin/ErbB Signaling in Developmental Myelin Formation and Nerve Repair.
Distress improves after mindfulness training for progressive MS: A pilot randomised trial.
Mosaicism for GJB1 mutation causes milder Charcot-Marie-Tooth X1 phenotype in a heterozygous man than in a manifesting heterozygous woman.
Commentary: Inflammation, Demyelination and Neurodegeneration: Risky Buddies in Multiple Sclerosis.
[Need for creating Polish registry of multiple sclerosis patients].
From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A.
Adherence Associated with Oral Medications in the Treatment of Spasticity.
Electrodiagnostics and clinical correlates in acquired polyneuropathies.
Mesenchymal cells of umbilical cord and umbilical cord blood as a source of human oligodendrocyte progenitors.
Autoantibodies against vinculin in patients with chronic inflammatory demyelinating polyneuropathy.
The interplay between bacillus Calmette-Guérin and Treg cells and its role to prevent or cure inflammatory diseases.
Label-fusion-segmentation and deformation-based shape analysis of deep gray matter in multiple sclerosis: The impact of thalamic subnuclei on disability.
Multiple sclerosis: Study reinforces need for contraception in women taking fingolimod.
Pages
« first
‹ previous
…
678
679
680
681
682
683
684
685
686
…
next ›
last »